<DOC>
	<DOCNO>NCT00893984</DOCNO>
	<brief_summary>In study investigator assess tolerance Nebivolol ( Bystolic ) cardiovascular patient able tolerate conventional beta blocker . A side effect profile track compare previous beta blocker use . The investigator hypothesize Bystolic tolerate many patient intolerant conventional blocker .</brief_summary>
	<brief_title>Alternative Beta Blocker Intolerance : The ABBI Trial</brief_title>
	<detailed_description>Patients prescribed standard beta blocker unable tolerate due side effect study . They take new beta blocker , Nebivolol ( Bystolic ) 30 day , tolerate . Side effect track compare previous .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Adrenergic beta-Antagonists</mesh_term>
	<mesh_term>Nebivolol</mesh_term>
	<criteria>Age â‰¥ 21 Male female postmenopausal pregnant use approved contraceptive regimen Previous beta blocker use intolerant beta blocker Systolic blood pressure &lt; 100 mmHg unless another blood pressure medication stop time study entry Hospitalized heart failure within past 4 week Bradycardia heart rate &lt; 60 Heart block great first degree History sick sinus syndrome ( unless permanent pacemaker place ) History severe hepatic renal dysfunction ; serum Creatinine &gt; 2.0 Amylase &gt; 3x normal Use CYP2D6 inhibitor ( quinidine , propafenone , fluoxetine , paroxetine , etc . ) Ingestion investigational drug within past 30 day</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Intolerance</keyword>
	<keyword>Beta blocker</keyword>
</DOC>